Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Neuronetrix, Inc.
With
University of Kentucky
Patients who have a current diagnosis of mild-moderate dementia and suspected of having Alzheimer's disease (AD) along with cognitively normal age-matched controls will be recruited for this study. The Alzheimer's subjects either will have had a complete clinical and neuropsychiatric workup or will have those tests performed during the study.
Both groups, AD and controls will be asked to listen to a series of sounds and press a button on a handheld control box when a target sound is heard. The COGNISION(TM) headset on each subject's head will then record the electrical signals during this task.
Four important features of the COGNISION(TM) will be investigated:
1. Patient tolerance
2. Ease of use
3. Data quality
4. Network architecture
Age
60–85
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Age 60 to 85
Mild to moderate diagnosis of Alzhiemer's disease
Age 60 to 85
Cognitively healthy with no complaints
You may not be if
Subjects with advanced AD and severe impairment (CDR \> 2, MMSE less than 15)
Neurological disorders such as stroke, Parkinson's disease, Huntington's disease, multiple sclerosis, brain tumor, delirium, or psychiatric disorder other than depression (e.g. schizophrenia)
Subjects with life threatening illnesses and subjects with significant hearing or visual impairments
Subjects with a current prescription for psychoactive pharmaceuticals
